Shorla Oncology will travel to NYC, US for the annual DCAT conference from 17-20 March 2019.
Shorla Oncology will travel to NYC, US for the annual DCAT conference from 17-20 March 2019.
Now approved for use in Pediatrics
Please click here for the full Prescribing information, including Boxed Warning regarding embryo-fetal toxicity, hypersensitivity reactions, and severe adverse reactions.